Literature DB >> 18787425

A comparison of synergeyes versus traditional rigid gas permeable lens designs for patients with irregular corneas.

Amy Catherine Nau1.   

Abstract

OBJECTIVES: To compare whether patients with irregular corneas are more comfortable wearing Synergeyes, a hybrid contact lens, compared with rigid gas permeable contact lenses.
METHODS: A retrospective chart review of patients seen from the specialty contact lens practice at the University of Pittsburgh, who were refit with hybrid lenses from November 2005 to December 2006. Inclusion criteria included presence of irregular astigmatism in at least one eye from any cause, prior use of rigid gas-permeable lenses within the past year in at least one eye, lens tolerance issues, and all day use of contacts to attain functional vision. Best corrected spectacle and hybrid lens corrected Snellen acuities, the number of lenses needed to complete the fitting, lens related complications, and whether patients preferred the Synergeyes or rigid lens after at least 3 months of follow-up were used as the variables to compare the safety and efficacy between the two lens modalities.
RESULTS: Seventy-nine eyes of 54 patients met criteria for inclusion. The average improvement over spectacle acuity was four Snellen lines with the Synergeyes lens. The average number of lenses required to successful fitting was 1.71. On review of patient opinions in follow-up, 79.5% of patients reported comfort was improved compared with rigid lenses, 13.5% said comfort was not better or the same, and 7% believed they were less comfortable.
CONCLUSIONS: In this population, the Synergeyes lens resulted in increased lens tolerability for many patients wearing therapeutic contacts. Patients who are otherwise unable to tolerate rigid gas permeable contacts should attempt use of a hybrid lens before resorting to penetrating keratoplasty.

Entities:  

Mesh:

Year:  2008        PMID: 18787425     DOI: 10.1097/ICL.0b013e31815c859b

Source DB:  PubMed          Journal:  Eye Contact Lens        ISSN: 1542-2321            Impact factor:   2.018


  8 in total

Review 1.  Complications of Refractive Surgery: Ectasia After Refractive Surgery.

Authors:  Meraf A Wolle; J Bradley Randleman; Maria A Woodward
Journal:  Int Ophthalmol Clin       Date:  2016

2.  Full-Ring Intracorneal Implantation in Corneas With Pellucid Marginal Degeneration.

Authors:  Sahar Mojaled Nobari; Consuelo Villena; Khosrow Jadidi
Journal:  Iran Red Crescent Med J       Date:  2015-12-26       Impact factor: 0.611

Review 3.  Nonsurgical Procedures for Keratoconus Management.

Authors:  L Rico-Del-Viejo; M Garcia-Montero; J L Hernández-Verdejo; S García-Lázaro; F J Gómez-Sanz; A Lorente-Velázquez
Journal:  J Ophthalmol       Date:  2017-12-21       Impact factor: 1.909

4.  A comparison of the visual acuity outcome between Clearkone and RGP lenses.

Authors:  Mohammadali Hassani; Ebrahim Jafarzadehpur; Ali Mirzajani; AbbasAli Yekta; Mehdi Khabazkhoob
Journal:  J Curr Ophthalmol       Date:  2017-08-26

5.  Mushroom keratoplasty and contact lens application: Strategy for management of a pediatric eye injury.

Authors:  Saverio V Luccarelli; Stefano Lucentini; Francesco Bonsignore; Paolo Nucci
Journal:  Indian J Ophthalmol       Date:  2019-07       Impact factor: 1.848

6.  Estimation of the hybrid lens parameters through rigid gas permeable lens fitting.

Authors:  Mohammadali Hasani; Hassan Hashemi; Ebrahim Jafarzadehpur; Abbas Ali Yekta; Nooshin Dadbin; Mehdi Khabazkhoob
Journal:  J Curr Ophthalmol       Date:  2016-06-28

7.  Fitting Tips and Visual Rehabilitation of Irregular Cornea with a New Design of Corneoscleral Contact Lens: Objective and Subjective Evaluation.

Authors:  Waleed Ali Abou Samra; Amani E Badawi; Hanem Kishk; Ayman Abd El Ghafar; Mohamed M Elwan; Hossam Youssef Abouelkheir
Journal:  J Ophthalmol       Date:  2018-02-01       Impact factor: 1.909

8.  Update on Contact Lens Treatment of Keratoconus

Authors:  Tomris Şengör; Sevda Aydın Kurna
Journal:  Turk J Ophthalmol       Date:  2020-08-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.